Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.797
+0.082 (11.47%)
At close: Jan 22, 2025, 4:00 PM
0.792
-0.005 (-0.58%)
After-hours: Jan 22, 2025, 4:06 PM EST
Renovaro Employees
Renovaro had 25 employees as of June 30, 2024. The number of employees increased by 13 or 108.33% compared to the previous year.
Employees
25
Change (1Y)
13
Growth (1Y)
108.33%
Revenue / Employee
n/a
Profits / Employee
-$4,627,487
Market Cap
126.48M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
RENB News
- 14 days ago - PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI - Business Wire
- 15 days ago - Renovaro Appoints Nathen Fuentes as Chief Financial Officer - GlobeNewsWire
- 15 days ago - Renovaro Issues Shareholder Letter and Provides Corporate Update - GlobeNewsWire
- 16 days ago - Renovaro to Acquire Predictive Oncology in All-Stock Transaction - GlobeNewsWire
- 23 days ago - Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV - GlobeNewsWire
- 4 weeks ago - RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program - GlobeNewsWire
- 4 weeks ago - Renovaro Regains Compliance with NASDAQ Listing Requirement - GlobeNewsWire
- 4 weeks ago - Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection - GlobeNewsWire